High-content imaging analysis of the knockdown effects of validated siRNAs and antisense oligonucleotides (Q33285354)

25 July 2017

title

High-content imaging analysis of the knockdown effects of validated siRNAs and antisense oligonucleotides (English)

1 reference

25 July 2017

Louis Stancato

11

0 references

author name string

Jonathan Low

1

1 reference

25 July 2017

Shuguang Huang

2

1 reference

25 July 2017

Michele Dowless

3

1 reference

25 July 2017

Wayne Blosser

4

1 reference

25 July 2017

Thomas Vincent

5

1 reference

25 July 2017

Scott Davis

6

1 reference

25 July 2017

Jeff Hodson

7

1 reference

25 July 2017

Erich Koller

8

1 reference

25 July 2017

Eric Marcusson

9

1 reference

25 July 2017

Kerry Blanchard

10

1 reference

25 July 2017

publication date

21 May 2007

1 reference

Journal of Biomolecular Screening

25 July 2017

published in

1 reference

25 July 2017

volume

12

1 reference

25 July 2017

issue

6

1 reference

25 July 2017

page(s)

775-788

1 reference

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

Novel antisense and peptide nucleic acid strategies for controlling gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

Role for a bidentate ribonuclease in the initiation step of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

Prospects of RNA interference therapy in respiratory viral diseases: update 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

Advances in high content screening for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

Antisense oligonucleotides as a tool for gene functionalization and target validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

A quantitative cell-based high-content screening assay for the epidermal growth factor receptor-specific activation of mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

Applying antisense technology: Affinitak and other antisense oligonucleotides in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057107302675

21 January 2018

Identifiers

DOI

10.1177/1087057107302675

1 reference

25 July 2017

1 reference